Astrana Health, Inc. (NASDAQ:ASTH) Short Interest Update

Astrana Health, Inc. (NASDAQ:ASTH) saw a significant decline in short interest in December. As of December 31st, there was short interest totalling 1,490,000 shares, a decline of 8.6% from the December 15th total of 1,630,000 shares. Based on an average trading volume of 303,600 shares, the short-interest ratio is presently 4.9 days. Approximately 4.2% of the company’s stock are short sold.

Analyst Ratings Changes

Several research firms have commented on ASTH. Robert W. Baird boosted their target price on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 13th. Truist Financial decreased their target price on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research report on Monday, January 13th. KeyCorp initiated coverage on shares of Astrana Health in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. TD Cowen initiated coverage on shares of Astrana Health in a report on Monday, October 14th. They set a “buy” rating and a $66.00 price objective for the company. Finally, Macquarie raised shares of Astrana Health to a “hold” rating in a report on Monday, December 16th. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $63.67.

Hedge Funds Weigh In On Astrana Health

Several large investors have recently bought and sold shares of ASTH. GAMMA Investing LLC acquired a new position in Astrana Health during the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at $35,000. KBC Group NV acquired a new position in shares of Astrana Health in the 3rd quarter valued at $70,000. Quarry LP acquired a new position in shares of Astrana Health in the 3rd quarter valued at $77,000. Finally, Quest Partners LLC acquired a new position in shares of Astrana Health in the 3rd quarter valued at $133,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Price Performance

NASDAQ:ASTH opened at $35.17 on Friday. The stock has a market cap of $1.98 billion, a P/E ratio of 27.05, a PEG ratio of 1.12 and a beta of 1.20. Astrana Health has a one year low of $29.08 and a one year high of $63.20. The company has a fifty day moving average price of $37.26 and a 200 day moving average price of $46.67. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting the consensus estimate of $0.33. The firm had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same period in the prior year, the company earned $0.47 EPS. Analysts anticipate that Astrana Health will post 1.16 earnings per share for the current year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.